RFK Jr., CDC panel casting doubt on the hepatitis B vaccine. Here's why it's safe
Last week, during the first meeting of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) since Kennedy removed all the previous sitting members and appointed seven new members, the chair questioned whether it was "wise" to administer shots "to every newborn before leaving the hospital."
Martin Kulldorff, a former Harvard Medical School professor, said a new work group would discuss the practice.
MORE: Experts warn RFK Jr. is unraveling the system that kept vaccines safe
Additionally, Kennedy claimed, without evidence, earlier this week during an interview with Tucker Carlson, that the CDC conducted a study that found the hepatitis B vaccine increases the risk of autism, and that researchers hid the results of the study from the public.
The HHS did not immediately respond to ABC News' request for the study that Kennedy referenced in his interview.
An infectious disease expert told ABC News that there is no evidence to suggest the hepatitis B vaccine is unsafe and that vaccinating babies at birth has been key to virtually eliminating the virus among children.
Hepatitis B is a liver infection caused by the hepatitis B virus, according to the CDC. The virus is transmitted from a person coming into contact with the blood, semen or other bodily fluid of someone who is infected.
Newborns might be infected through the process of birth or from casual contact, because the virus can survive in the environment for about a week, Dr. Peter Chin-Hong, an infectious disease specialist at the University of California, San Francisco, told ABC News.
Up to half of all older children, adolescents and adults have symptoms of acute hepatitis B. Most children younger than age 5, however, have no symptoms, the CDC said.
"Hepatitis B … causes inflammation in the liver …and that inflammation leads to the liver not working well at all," Chin-Hong said. "So that's cirrhosis and liver failure and, ultimately, also liver cancer. The longer you have hepatitis B, the higher the risk of cirrhosis or liver failure and liver cancer."
Acute hepatitis B infection, which is a short-term illness, can lead to a lifelong infection known as chronic hepatitis B, according to the CDC
Chin-Hong said that means if somebody is born with hepatitis B or infected as a child, they have a high chance of liver failure or liver cancer as an adult.
Chin-Hong said the best way for someone to prevent hepatitis B and to protect themselves is by getting vaccinated.
The vaccine was first developed in the early 1980s. Depending on the vaccine brand, the hepatitis B vaccine is either a series of two or three shots, according to the CDC.
MORE: RFK Jr. has questioned rising autism rates. Here's what experts say he gets wrong about the disorder
The childhood immunization schedule recommends babies be vaccinated at birth with a second dose between one and two months old and a potential third dose from 6 months to 15 months old.
"The more shots you get, the higher the chance the vaccine will take," Chin-Hong said. "If you get three shots, it's above 97% efficacy."
In 1991, when the ACIP recommended universal vaccination for hepatitis B among infants to decrease transmission, there were 18,000 cases of hepatitis B in those under 10 years old in the U.S., according to the CDC.
Since then, cases have dramatically decreased. CDC data shows that in 2022, the rate of cases among those ages 19 was less than 0.1 per 100,000.
"It's very, very rare," Chin-Hong said. "So, we've had a big success, and the United States is a mirror for the rest of the world … 97% of countries now have a recommendation for hepatitis B vaccination in infants. It's really changed the face of not only infection and liver failure, but also liver cancer."
During the ACIP meeting last week, Kulldorff implied that children receive too many vaccines nowadays compared to decades ago.
"The number of vaccines that our children and adolescents receive today exceeds what children in most other developed nations receive and what most of us in this room received when we were children," Kulldorff said.
Chin-Hong said that by adding vaccines to the immunization schedule, children have more protection against diseases compared to 10 or even 20 years ago, and the makeup of vaccines is also different.
"The way that we're delivering the vaccines is very different," he said. "They're through smaller bits of the virus instead of the whole virus itself or bacteria. So, it means that infants are exposed to actually fewer antigens. or parts of the virus or bacteria, with better vaccines."
The ACIP announcing that well-studied vaccines, like the hepatitis B vaccine, are going to be reanalyzed could make people think the initial approval process was unsafe, according to Chin-Hong.
As for Kennedy's claim, the HHS secretary has been a long-time vaccine skeptic who refused to say during his confirmation hearings earlier this year that vaccines don't cause autism despite many high-quality studies finding no such link.
"There's no evidence that the hepatitis B vaccine leads to autism or is a risk factor for autism, and that is unquestionable," Chin-Hong said.
ABC News' Youri Benadjaoud contributed to this report.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
an hour ago
- Forbes
A Promising New AIDS Drug Highlights The Dangers Of Price Controls
"The progress that science has made against HIV/AIDS is nothing short of remarkable," writes health ... More policy expert Sally Pipes. The U.S. Food and Drug Administration approved a shot last month that effectively prevents HIV. At-risk people simply need to receive the injection every six months. The new drug, called lenacapavir, comes almost exactly 44 years after the first case of AIDS was reported by what's now known as the Centers for Disease Control and Prevention, or CDC. The progress that science has made against HIV/AIDS is nothing short of remarkable. For much of the last four decades, a diagnosis of HIV/AIDS was a death sentence. At the peak of the AIDS crisis in 1995, the death rate for HIV/AIDS was just over 16 for every 100,000 people. By 2019, it had fallen to just over one per 100,000. This progress was due almost entirely to advances in pharmaceutical treatment, which turned AIDS from a deadly plague to a chronic condition. Some 16.5 million lives were saved by AIDS drugs between 2001 and 2021. According to the World Health Organization, in 2023 around 72% of people living with HIV/AIDS had a suppressed viral load—meaning the disease was undetectable and mostly untransmittable, thanks to medication. And now, lenacapavir has been shown to provide 'a near-perfect shield against HIV infection,' as the New York Times put it. But the drug was not invented overnight. It's been in the works for 20 years, the product of countless scientists engaging in costly, high-stakes research. The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical sector. Unfortunately, lawmakers are working to upend the very system that makes drugs like lenacapavir possible. Democrats have long sought to impose European-style price controls in the United States. Republicans—including President Trump, who has expressed enthusiasm for price controls on prescription drugs—are embracing similar plans in increasing numbers. Researchers first isolated the molecule that would become lenacapavir in 2016. That discovery was itself the end result of two decades of research. It would take another 10 years for researchers to bring that molecule to market. As Dr. William Pao noted in a recent STAT News piece, 'Lenacapavir breaks all of [the] rules' of HIV/AIDS treatment. By the time it was isolated, there were already a number of effective HIV/AIDS treatments on the market. Developing a new, unconventional treatment didn't make much sense. But, as Pao notes, '[E]very challenge can be turned into an opportunity for innovation with some creative thinking, and that is exactly what Gilead did.' Bringing a new drug from the lab to the market—even one less innovative than lenacapavir—is risky and expensive. It takes between 10 and 15 years and costs around $2.6 billion, on average. Of every 100 drugs that enter clinical trials, fewer than eight ever make it to pharmacy shelves. Drug companies use the money from successful drugs to offset the cost of failures. And they're willing to take a chance on new projects precisely because they know that, in the United States, they will have an opportunity to recoup and earn a return on their investments. The economic reality in countries that impose price controls on pharmaceuticals is different. Those price caps limit drug companies' potential return on novel medicines. So they tend to delay entry into those markets. One study found that, as of October 2022, patients in Canada had access to just 45% of drugs launched worldwide between 2012 and 2021. For patients in the United Kingdom, the corresponding figure was just 59%. In the United States, patients had access to 85% of those drugs. Yet American lawmakers are still working to implement price controls here. The Trump administration recently revived the 'most favored nation' policy from 2020, which would link the U.S. prices of drugs to the lowest price paid in other developed countries. If this system had been in place 20, 10, or even five years ago, it's possible that lenacapavir never would have made it to market—to say nothing of the countless other drugs for AIDS and other diseases that have been developed in recent years. For future patients' sake, let's hope lawmakers abandon their plans to impose price controls—and allow a healthy market for pharmaceuticals to flourish.
Vox
an hour ago
- Vox
The US just recorded the most measles cases in 30 years
covers health for Vox, guiding readers through the emerging opportunities and challenges in improving our health. He has reported on health policy for more than 10 years, writing for Governing magazine, Talking Points Memo, and STAT before joining Vox in 2017. The US has seen more measles cases in 2025 than in any year since US has now recorded 1,277 measles cases this year, according to case data collected by Johns Hopkins University, making the current outbreak the most severe since 1992. The disease continues to spread, and by now most schools are out for the summer. July summer camps have opened and family vacations are picking up — all creating new opportunities for the virus to transmit. The next few months will be crucial for getting measles under control in the US. Three people have already died this year, the first measles deaths in the country in a decade. Most of the cases have been concentrated in a major outbreak in the Southwest — in New Mexico, Oklahoma, and Texas — but the virus is now also spreading in Arkansas, Illinois, Indiana, Kansas, Michigan, and Ohio. New outbreaks have recently sparked in Colorado, Montana and North Dakota. Though cases are still rising, they're doing so more modestly than they were in March, when the country was seeing 100 or more new cases in a week. The measles outbreak does appear to be slowing down, experts say. But as cases continue to spread, the Centers for Disease Control and Prevention in mid-June urged kids' summer camps to check their participants for measles immunity status. Measles is one of the world's most contagious viruses and, with vaccination rates declining among children across the country, a lot of kids tightly cloistered for several days creates a prime environment for measles to spread quickly once introduced. The CDC's new checklist for summer camps advises camp organizers to collect vaccine records from campers and keep the documentation on hand, to check campers and staff for any signs of fever or rash upon arrival, and to set up an isolation area if anyone begins to feel sick once camp has started. We are living in a new reality: Measles is spreading widely, vaccination rates are down, and the country's top health official, Robert F. Kennedy Jr., has backed away from urging vaccination — even though they are 97 percent effective — as the best way to tamp down on measles' spread. Kennedy has installed a new expert vaccine committee, opening up a review of the childhood vaccination schedule that includes the MMR shot. Given this more lax approach from the Trump administration, now is a good time to look out for ourselves and our loved ones. Here's what you need to know about measles as the season with the biggest potential to spread heats up: Measles is an extremely contagious and dangerous virus The US has been largely free of measles — a disease that still kills over 100,000 people worldwide every year, most of them young children — since the 1990s. Its risks have for most people become largely hypothetical. But for unvaccinated Americans, those risks remain very real. Measles is an extremely contagious virus that can lead to high fever and rash. Some patients develop pneumonia or encephalitis, a brain inflammation, both of which can be deadly. Measles has a fatality rate of 0.1 percent, but about 20 percent of cases can put patients in the hospital. The virus can be particularly dangerous for kids, especially young infants, as well as pregnant women and people who are immunocompromised. Some vaccine skeptics, including Kennedy, downplay the measles' risk. 'It used to be, when I was a kid, that everybody got measles. And the measles gave you lifetime protection against measles infection,' he said on Fox News in March. But measles has never been some harmless disease: In the decade before a vaccine was introduced in 1963, between 400 to 500 children died annually from measles in the US. From 1968 to 2016, there were about 550 measles deaths total in the US, according to the CDC. But before this year, it had been 10 years since any measles deaths had been recorded in the US. Even people who survive a measles infection can endure long-term health consequences, the risks of which are greater for vulnerable groups. Some of those infected in the current outbreak may have their health affected for years. Measles can cause what's called immunity amnesia. The virus can wipe out more than half a person's preexisting antibodies that provide protection against other pathogens. That can leave the patient at higher risk from other diseases for years after their measles infection. And in very rare cases, measles can lead to fatal brain swelling years after the initial infection. Patients can also experience hearing loss from ear infections that started their illness, while the people who develop acute encephalitis can suffer permanent neurological damage. You can protect your kids from measles. Here's how. Vaccination is without a doubt the best defense against measles: two doses of the MMR vaccine — given to protect against measles, mumps, and rubella. It is one the most effective vaccines we have for any disease, and any risks from the vaccine are extremely low when compared to the dangers of measles itself. But in this new world, you're more likely to see a measles outbreak in your community. People may want to be more proactive about protecting themselves and their loved ones. Here's what you can do: Parents of young children — the group most at risk from measles — should talk to their pediatrician about measles vaccination. Children usually get their first shot around the time they turn 1 and receive another shot around age 5, but there is some flexibility. The CDC recommends that infants as young as 6 months receive one dose if they are traveling internationally, and the recommended age for the second dose ranges from 4 to 6 years old. Several leading public health experts, including former CDC director Rochelle Walensky, wrote in a JAMA op-ed over the spring that the recommendations should be updated to advise one shot for infants traveling in the US to areas with higher risk of exposure. There have been reports of vaccinated individuals getting infected during the current outbreaks, which has raised questions about how protected vaccinated people actually are. As good as it is, 97 percent effectiveness is not 100 percent, and it is possible to be vaccinated against measles and still get sick. For a very small percentage of people, the vaccine simply doesn't produce immunity. It is also possible that immunity could wane over time, but that was previously not an issue because high vaccination rates had snuffed out the virus's spread. Per the CDC's estimates, about 3 percent of measles cases this year have been vaccinated people — consistent with the 97 percent efficacy rate. The priority should be vaccinating those people who do not have any protection at all: very young children and the people who weren't vaccinated as kids. Pregnant women should not receive the vaccine, but women planning to become pregnant could consult with their doctor about a booster shot; likewise, people with immune conditions should talk to their doctor before getting any additional doses, because the vaccine's live virus could present a risk depending on how compromised their immune system is. People who are at a higher risk may want to take extra precautions, such as wearing a face covering, if there are any reports of measles infections in their immediate area. For other people who have already been vaccinated but are still worried about transmission, it may be reasonable to consider a booster shot. But there are some important steps you should take first. First, check your vaccination records if you can find them. Anyone who received two doses as a child very likely had a successful immune response; only three in 100 people don't. And if you received one dose — which was generally the norm before 1989 — you're probably still protected, but it is slightly more likely that you never developed immunity, Aaron Milstone, an infectious disease pediatrician at the Johns Hopkins University School of Medicine, told me earlier this year. The next step would be to talk to your doctor, who can give you a 'titer test' that measures the measles antibodies in your body. If they're still present — then you should be good. But if they're not, you may want to ask your doctor about getting an additional measles shot. The risks from measles should be kept in context: If you're not near any confirmed measles cases, your personal risk probably remains low. If you're vaccinated and have antibodies, you are very likely protected from the virus even if there is local transmission. But summer travel introduces some new risks: Several smaller outbreaks this year have been traced to infectious travelers passing through US airports. But measles can not be ignored either. Milstone said he and his fellow infectious disease doctors could not believe it when they heard the news in February of a child's death from measles in the United States of America.
New York Post
an hour ago
- New York Post
Morning workouts can boost weight loss if one key habit is followed, experts claim
Exercising first thing in the morning can be beneficial for mental and physical health. In terms of weight loss, previous research suggests that early morning may be the best time to exercise, according to the CDC's National Health and Nutrition Examination Survey. Advertisement The research, published in the journal Obesity, recorded the activity levels of 5,285 participants, taking into consideration the time of day they exercised. Those who consistently engaged in morning activity, between 7 a.m. and 9 a.m., were found to have a lower risk of obesity than those who were most active in the midday or evening. The morning exercisers also had a lower average BMI (body mass index) and waist size. Certified fitness trainer Alissa Mosca with Planet Fitness in New York agreed that morning workouts are a 'great way' to start the day. Advertisement 'When the day begins with a morning workout routine, the body releases multiple different chemicals, which aid in our overall functionality,' she told Fox News Digital. 'This includes chemicals like endorphins and dopamine, which are the chemicals that make us feel good and help us move forward with positive energy. Additionally, we wake up our muscles, stimulate the brain, and prepare to take on the day.' 4 Exercising first thing in the morning can be beneficial for mental and physical health. Jacob Lund – The sleep-exercise balance Sleep and wellness expert Todd Anderson, co-founder of Dream Performance & Recovery in Nashville, Tennessee, emphasized the importance of striking a healthy balance between exercise and rest. Advertisement The first couple of hours of exercise in a week are 'insanely impactful,' Anderson said — and it doesn't have to be a strenuous activity. 'Our bodies are meant to move,' he said. 'Getting two hours of movement or exercise in a week should be very high on the priority list.' 4 In terms of weight loss, previous research suggests that early morning may be the best time to exercise, according to the CDC's National Health and Nutrition Examination Survey. Antonioguillem – While it might seem that morning exercise is cutting into sleep time, Anderson pointed out that regular exercise could actually result in a higher quality of slumber. Advertisement 'The sleep you're getting will be more impactful,' he said. But for people who hit the gym daily and don't get sufficient shuteye, Anderson said he considers it a 'no-brainer' to opt for adequate sleep over an early-morning workout. 'When it comes down to body composition and weight loss or just fitness in general, you'll probably have a better outcome from that hour of sleep when you're already at a pretty decent level of activity,' he said. 'When you sleep, it allows you to respond effectively to the stress from the workouts.' Mosca agreed that proper rest and recovery require seven to eight hours of sleep, which allows the muscles to have the greatest amount of repair and growth. 'If someone is going to bed at 12 a.m. to 1 a.m. nightly and then trying to wake up for a 6 a.m. workout, the progress will stall and the effects of the hard work that is put in will take that much longer to come to light,' she told Fox News Digital. 'Getting on a regular sleep schedule, unwinding earlier, putting the electronics down, and focusing on calming the mind will allow someone to recover faster, have more energy in the morning, and release those happy brain chemicals that make us feel accomplished.' Advertisement The trainer stressed that morning workouts are not for everyone, and there are certain factors that can prevent success. For those considering a morning workout, Mosca recommends that they ask themselves the following questions. 'Did I get enough sleep the night before?' 4 While it might seem that morning exercise is cutting into sleep time, regular exercise could actually result in a higher quality of slumber, according to sleep and wellness expert Todd Anderson. Andrey Popov – Advertisement 'How was my nutritional intake?' 'Am I overly stressed?' 'Do I keep hitting snooze when the alarm goes off?' Every morning, the NY POSTcast offers a deep dive into the headlines with the Post's signature mix of politics, business, pop culture, true crime and everything in between. Subscribe here! Advertisement 'If we find that the answers to those questions [aren't] on the positive side, consider an afternoon mini-workout: 15 to 20 minutes after work or on break, to get the muscles moving and stimulated,' Mosca suggested as an alternative. 4 But for people who hit the gym daily and don't get sufficient shuteye, Anderson said he considers it a 'no-brainer' to opt for adequate sleep over an early-morning workout. New Africa – 'The body adjusts the more that it moves and the more it is in a consistent routine. Taking the right steps to change the routine is crucial, so we don't overload the body all at once.' Advertisement Mosca reiterated that sleep and recovery play a 'crucial role' in fitness journey success. 'If we shorten the timeframe for our bodies to recover, they will constantly be trying to play catch-up, but never reaching that finish line,' she said. 'We want to set clear goals and reasonable expectations.'
